Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
EIF2B5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
LOC105372547 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SYK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C14orf166 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CENPM - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
METTL26 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYO19 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
APRT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NID1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
TOP1MT - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101060604 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GNAO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PI4KA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TELO2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FSD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PDDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on